NCT02750007View on ClinicalTrials.gov

Tolerability to HS-20004 With Titration Administration in Type 2 Diabetic Patients

PHASE1UnknownINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

January 31, 2017

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

HS-20004

Trial Locations (1)

410011

RECRUITING

The Second Xiangya Hospital of Central South University, Changsha

Sponsors
All Listed Sponsors
lead

Jiangsu Hansoh Pharmaceutical Co., Ltd.

INDUSTRY